首站-论文投稿智能助手
典型文献
Peripheral Blood miRNA Integrated Analysis on the Diagnostic Significance of miR-455-3p in Prostate Cancer
文献摘要:
Objective: To screen peripheral blood microRNA (miRNA) as biomarkers for prostate cancer diagnosis, the bioinformatics methods have been established. Methods: The miRNA differential expression dataset (GSE206793 and GSE112264) in the plasma of prostate cancer patients were downloaded on the website of GEO database. Firstly, the differential miRNAs in both of the two datasets were screened by bio-credit analysis. The screened miRNA was analyzed by KEGG signaling pathway and GO enrichment analysis. TF-miRNA network was constructed for upstream regulatory transcription factors. Subsequently, protein-protein interaction (PPI) network was constructed for target genes using STRING database. Finally, the expression levels of the differentially expressed miRNAs in different prostate cancer stages were analyzed in the two datasets. Results:This study found that miR-455-3p was differentially expressed in both datasets. Signal pathway analysis showed that miR-455-3p was enriched in different pathways, including autophagy, cell entry and neurotrophic factors. PPI network showed that the interacting proteins mainly included HDAC2, H2AFZ, SALL1, NCOR2, and MAP3K1. Moreover, miR-455-3p was significantly increased in prostate cancer patients with different stages and risk grades. The ROC curve results showed AUC values of 0.943 and 0.847 for the two datasets, respectively. Conclusion: This study proved that miR-455-3p in peripheral blood can be used as a biomarker for prostate cancer diagnosis.
文献关键词:
作者姓名:
YAN Cheng-ming;ZHU Guang-bin;LI Chang-yong;LI Ming-jie
作者机构:
Fuzhou Center for Disease Control,Fuzhou Fujian 350005,China;Department of Radiology,the Fifth Hospital of Guangzhou Medical University,Guangzhou Guangdong 510799,China;Department of Radiobiology,Beijing Institute of Radiation Medicine,Beijing 100850,China;Affiliated Hospital of Qingdao University,Qingdao Shandong 266071,China
引用格式:
[1]YAN Cheng-ming;ZHU Guang-bin;LI Chang-yong;LI Ming-jie-.Peripheral Blood miRNA Integrated Analysis on the Diagnostic Significance of miR-455-3p in Prostate Cancer)[J].中国生物医学工程学报(英文版),2022(03):129-138
A类:
GSE206793,GSE112264
B类:
Peripheral,Blood,Integrated,Analysis,Diagnostic,Significance,3p,Prostate,Cancer,Objective,To,peripheral,blood,microRNA,biomarkers,prostate,cancer,diagnosis,bioinformatics,methods,have,been,established,Methods,expression,plasma,patients,were,downloaded,website,GEO,database,Firstly,miRNAs,both,datasets,screened,by,credit,analysis,was,analyzed,signaling,enrichment,TF,network,constructed,upstream,regulatory,transcription,factors,Subsequently,interaction,PPI,target,genes,using,STRING,Finally,levels,differentially,expressed,stages,Results,This,study,found,that,Signal,showed,enriched,pathways,including,autophagy,cell,entry,neurotrophic,interacting,proteins,mainly,included,HDAC2,H2AFZ,SALL1,NCOR2,MAP3K1,Moreover,significantly,increased,risk,grades,curve,results,values,respectively,Conclusion,proved,used
AB值:
0.516487
相似文献
Microrna-1224-5p Is a Potential Prognostic and Therapeutic Biomarker in Glioblastoma:Integrating Bioinformatics and Clinical Analyses
Xing WEI;Qing-mei ZHANG;Chang LIU;Song WU;Wei-xia NONG;Ying-ying GE;Li-na LIN;Feng LI;Xiao-xun XIE;Bin LUO-Department of Histology and Embryology,School of Pre-clinical Medicine,Guangxi Medical University,Nanning 530021,China;Department of Neurology,the First Affiliated Hospital,Guangxi Medical University,Nanning 530021,China;Central Laboratory of Pre-Clinical Medicine(Key Laboratory of Guangxi Colleges and Universities),Guangxi Medical University,Nanning 530021,China;Department of Neurosurgery,the First Affiliated Hospital,Guangxi Medical University,Nanning 530021,China;Key Laboratory of Early Prevention and Treatment of Regional High Frequency Tumor(Guangxi Medical University),Ministry of Education,Nanning 530021,China
Overexpression of MiR-633 Suppresses the Tumorigenicity of Gastric Cancer Cells and Induces Apoptosis by Targeting MAPK1
Hai-long LI;Yao-hui SONG;Zheng-ping DU;Yong-hua HU;Zhuan-xiong WANG;Xi CHEN;Xing-mei LU;Ying-xia CHEN;Yong-qiang DUAN;Xiang-dong ZHU-Department of Geriatrics,Affiliated Hospital of Gansu University of Traditional Chinese Medicine,Lanzhou 730000,China;Department of Internal Medicine,The First Clinical Medical College,Gansu University of Chinese Medicine,Lanzhou 730000,China;Provincial-Level Key Laboratory for Molecular Medicine of Major Diseases and The Prevention and Treatment with Traditional Chinese Medicine in Gansu Colleges and Universities,Gansu University of Chinese Medicine,Lanzhou 730000,China;School of Basic Medicine,Gansu Vocational College of Health,Lanzhou 730300,China;College of Traditional Chinese Medicine,Ningxia Medical University,Yinchuan 750004,China
High Expression of Fibronectin 1 Predicts a Poor Prognosis in Glioblastoma
Song WU;Chang LIU;Xing WEI;Wei-xia NONG;Li-na LIN;Feng LI;Xiao-xun XIE;Xing-sheng LIAO;Bin LUO;Qing-mei ZHANG;Shao-wen XIAO-Department of Neurosurgery,the First Affiliated Hospital,Guangxi Medical University,Nanning 530021,China;Department of Histology and Embryology,School of Pre-clinical Medicine,Guangxi Medical University,Nanning 530021,China;Department of Neurology,the First Affiliated Hospital,Guangxi Medical University,Nanning 530021,China;Key Laboratory of Early Prevention and Treatment of Regional High Frequency Tumor(Guangxi Medical University),Ministry of Education,Nanning 530021,China;Central Laboratory of Pre-Clinical Medicine(Key Laboratory of Guangxi Colleges and Universities),Guangxi Medical University,Nanning 530021,China
Pathological Change of Chronic Hepatitis B Patients with Different Tongue Coatings by Circular Multi-omics Integrated Analysis
TANG Yi-shuang;GUO Jian-chun;XU Lin;ZHANG Xiao-na;SHEN Xiao-ping;HAI Ya-mei;MAO Yu-feng;HU Yi-yang;ZHAO Yu-Key Laboratory of Liver and Kidney Diseases,Institute of Liver Diseases,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203 ,China;Department of Integrated Chinese and Western Medicine,Hangzhou Xixi Hospital,Hangzhou 310023 ,China;National Engineering Center for Biochip at Shanghai,Shanghai 201203 ,China;Institute of Clinical Pharmacology,Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203 ,China;Shanghai Key Laboratory of Traditional Chinese Clinical Medicine,Shanghai 201203 ,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。